115 related articles for article (PubMed ID: 37486696)
1. Transferrin receptor modulated by microRNA-497-5p suppresses cervical cancer cell malignant phenotypes.
Fang X; Hu P; Gao Y; Chen C; Xu J
Adv Clin Exp Med; 2024 Mar; 33(3):273-282. PubMed ID: 37486696
[TBL] [Abstract][Full Text] [Related]
2. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
3. LncRNA LINC00888 upregulation predicts a worse survival of laryngeal cancer patients and accelerates the growth and mobility of laryngeal cancer cells through regulation of miR-378g/TFRC.
Cui P; Dai X; Liu R; Cao H
J Biochem Mol Toxicol; 2021 Oct; 35(10):e22878. PubMed ID: 34472153
[TBL] [Abstract][Full Text] [Related]
4. Effects of miR-9-5p on the migration, invasion and epithelial-mesenchymal transition process in cervical squamous cell carcinoma.
Kuang T; Li L; Chen Y; Wang J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 48(1):15-23. PubMed ID: 36935173
[TBL] [Abstract][Full Text] [Related]
5. CircRNA VPRBP inhibits tumorigenicity of cervical cancer via miR-93-5p/FRMD6 axis.
Shen L; Dang J; Liu S; Xian B; Deng Y; Qu D
Reprod Sci; 2022 Aug; 29(8):2251-2264. PubMed ID: 35501594
[TBL] [Abstract][Full Text] [Related]
6. MiR-499b-5p inhibits cervical cancer cell proliferation and induces apoptosis by targeting the Notch1 signaling pathway.
Liu HM; Ji F; Lu Y; Chen SY
Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6220-6231. PubMed ID: 34730202
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-125a-5p modulates human cervical carcinoma proliferation and migration by targeting ABL2.
Qin X; Wan Y; Wang S; Xue M
Drug Des Devel Ther; 2016; 10():71-9. PubMed ID: 26766902
[TBL] [Abstract][Full Text] [Related]
8. ATG9A modulated by miR-195-5p can boost the malignant progression of cervical cancer cells.
Liu X; Liu Z; Liu Y; Wang N
Epigenetics; 2023 Dec; 18(1):2257538. PubMed ID: 37782756
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-493-5p promotes apoptosis and suppresses proliferation and invasion in liver cancer cells by targeting VAMP2.
Wang G; Fang X; Han M; Wang X; Huang Q
Int J Mol Med; 2018 Mar; 41(3):1740-1748. PubMed ID: 29328362
[TBL] [Abstract][Full Text] [Related]
10. Circ_SEC61A1 contributes to the progression of multiple myeloma cells via regulating miR-660-5p/CDK6 axis.
Luo Z; Yin Y; Tan X; Liu K; Chao Z; Xia H
Leuk Res; 2022 Feb; 113():106774. PubMed ID: 35030455
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA LINC00460 promotes proliferation and inhibits apoptosis of cervical cancer cells by targeting microRNA-503-5p.
Lin L; Xin B; Jiang T; Wang XL; Yang H; Shi TM
Mol Cell Biochem; 2020 Dec; 475(1-2):1-13. PubMed ID: 32740791
[TBL] [Abstract][Full Text] [Related]
12. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X
Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mTOR signaling pathway.
Li YM; Li XJ; Yang HL; Zhang YB; Li JC
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4688-4697. PubMed ID: 31210295
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of NOB1 by microRNA-330-5p overexpression represses cell growth of non-small cell lung cancer.
Kong R; Liu W; Guo Y; Feng J; Cheng C; Zhang X; Ma Y; Li S; Jiang J; Zhang J; Qiao Z; Qin J; Lu T; He X
Oncol Rep; 2017 Oct; 38(4):2572-2580. PubMed ID: 28849232
[TBL] [Abstract][Full Text] [Related]
15. MiR-200c-3p and miR-485-5p overexpression elevates cisplatin sensitivity and suppresses the malignant phenotypes of non-small cell lung cancer cells through targeting RRM2.
Liu Y; Zhang Y; Li Q; Xu R; Huang N
Thorac Cancer; 2022 Jul; 13(13):1974-1985. PubMed ID: 35599447
[TBL] [Abstract][Full Text] [Related]
16. miR-199a-5p promotes proliferation and metastasis and epithelial-mesenchymal transition through targeting PIAS3 in cervical carcinoma.
Qu D; Yang Y; Huang X
J Cell Biochem; 2019 Aug; 120(8):13562-13572. PubMed ID: 30937952
[TBL] [Abstract][Full Text] [Related]
17. MiR-296-5p suppresses papillary thyroid carcinoma cell growth via targeting PLK1.
Zhou SL; Tang QL; Zhou SX; Ren RZ
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2084-2091. PubMed ID: 30915753
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-98-5p modulates cervical cancer progression via controlling PI3K/AKT pathway.
Xiao R; Wang H; Yang B
Bioengineered; 2021 Dec; 12(2):10596-10607. PubMed ID: 34895048
[TBL] [Abstract][Full Text] [Related]
19. LncRNA TDRG1 promotes the proliferation, migration, and invasion of cervical cancer cells by sponging miR-214-5p to target SOX4.
Guo M; Lin B; Li G; Lin J; Jiang X
J Recept Signal Transduct Res; 2020 Jun; 40(3):281-293. PubMed ID: 32106739
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-101-5p inhibits the growth and metastasis of cervical cancer cell by inhibiting CXCL6.
Shen W; Xie XY; Liu MR; Wang LL
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1957-1968. PubMed ID: 30915738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]